v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
Current assets:      
Cash and cash equivalents $ 6,021 $ 12,118 $ 15,321
Short-term investments   0 10,151
Prepaid expenses and other current assets 6,561 350 427
Total current assets 12,582 12,468 25,899
Non-current assets      
Property and equipment, net 3 8 3,334
Right-of-use asset 392 547 947
Other non-current assets 1,014 1,019 1,065
Deferred offering costs 5,138 1,888 0
Total assets 19,126 15,922 31,245
Current liabilities:      
Accounts payable 6,554 5,290 5,875
Accrued expenses and other current liabilities 4,412 3,460 3,130
Deferred revenue, current   650 71
Lease liabilities, current 255 309 418
Term loan 22,893 7,500  
Total current liabilities 34,114 17,209 9,494
Non-current liabilities      
Lease liabilities, non-current 124 239 565
Deferred Revenue, Noncurrent   0 71
Total liabilities 34,238 17,448 10,130
Stockholders' equity:      
Common shares 17 17 10
Additional paid-in capital   2,142 0
Accumulated other comprehensive income (loss) (1,817) (1,791) (1,753)
Accumulated deficit (197,518) (179,900) (143,332)
Total stockholders' equity (180,351) (160,565) (126,108)
Total liabilities and stockholders' equity 19,126 15,922 31,245
Previously Reported [Member]      
Non-current assets      
Other non-current assets   2,899  
Redeemable Convertible Preferred Shares Series Seed Preferred Shares      
Redeemable convertible preferred shares      
Redeemable convertible preferred shares 994 919 785
Redeemable Convertible Preferred Shares Series B Preferred Shares      
Redeemable convertible preferred shares      
Redeemable convertible preferred shares 30,088 28,966 26,825
Redeemable Convertible Preferred Shares Series C-1 Preferred Shares      
Redeemable convertible preferred shares      
Redeemable convertible preferred shares 84,780 81,714 75,859
Redeemable Convertible Preferred Shares Series C-2 Preferred Shares      
Redeemable convertible preferred shares      
Redeemable convertible preferred shares 49,377 47,440 43,754
Total Redeemable Convertible Preferred Shares      
Redeemable convertible preferred shares      
Redeemable convertible preferred shares 165,239 159,039 147,223
Series A Preferred Stock      
Stockholders' equity:      
Preferred shares 18,967 18,967 18,967
IKENA ONCOLOGY INC      
Current assets:      
Cash and cash equivalents 58,290 39,393 119,894
Marketable securities 37,352 84,993 55,571
Prepaid expenses and other current assets 3,371 2,783 3,197
Total current assets 99,013 127,169 178,662
Non-current assets      
Property and equipment, net 419 593 2,335
Right-of-use asset 2,561 3,635 5,686
Deposits and other assets 24,173 10,113 5,409
Total assets 126,166 141,510 192,092
Current liabilities:      
Accounts payable 512 897 2,066
Accrued expenses and other current liabilities 2,978 6,097 8,581
Lease liabilities, current 3,834 3,784 3,558
Total current liabilities 7,324 10,778 14,205
Non-current liabilities      
Lease liabilities, non-current 1,843 3,737 7,180
Other long-term liabilities 1,092 1,061 950
Total liabilities 10,259 15,576 22,335
Commitments and contingencies
Stockholders' equity:      
Preferred shares 0 0 0
Common shares 4 4 4
Additional paid-in capital 458,843 457,481 452,186
Accumulated other comprehensive income (loss) 65 68 (48)
Accumulated deficit (343,005) (331,619) (282,385)
Total stockholders' equity 115,907 125,934 169,757
Total liabilities and stockholders' equity $ 126,166 $ 141,510 $ 192,092